407 related articles for article (PubMed ID: 15756580)
1. Intravitreal triamcinolone acetonide in sympathetic ophthalmia.
Ozdemir H; Karacorlu M; Karacorlu S
Graefes Arch Clin Exp Ophthalmol; 2005 Jul; 243(7):734-6. PubMed ID: 15756580
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia.
Jonas JB
Am J Ophthalmol; 2004 Feb; 137(2):367-8. PubMed ID: 14962439
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
4. Rapid recovery of sympathetic ophthalmia with treatment augmented by intravitreal steroids.
Chan RV; Seiff BD; Lincoff HA; Coleman DJ
Retina; 2006 Feb; 26(2):243-7. PubMed ID: 16467694
[No Abstract] [Full Text] [Related]
5. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
Ozdemir H; Karacorlu M; Karacorlu SA
Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal steroid slow-release device replacing repeated intravitreal triamcinolone injections for sympathetic ophthalmia.
Jonas JB; Rensch F
Eur J Ophthalmol; 2008; 18(5):834-6. PubMed ID: 18850570
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
9. Repeated intravitreal triamcinolone acetonide for chronic sympathetic ophthalmia.
Jonas JB; Spandau UH
Acta Ophthalmol Scand; 2006 Jun; 84(3):436. PubMed ID: 16704716
[No Abstract] [Full Text] [Related]
10. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Ozdemir H; Karacorlu M; Karacorlu S
Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide treatment for serpiginous choroiditis.
Adigüzel U; Sari A; Ozmen C; Oz O
Ocul Immunol Inflamm; 2006 Dec; 14(6):375-8. PubMed ID: 17162609
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
Saraiva VS; Sallum JM; Farah ME
Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone for macular edema in Lyme disease.
Reibaldi M; Faro S; Motta L; Longo A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):457-8. PubMed ID: 18193264
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Jonas JB; Kreissig I; Degenring RF
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):782-3. PubMed ID: 12271378
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
